Man Group
KRON

Man Group’s Kronos Bio KRON Stock Holding History

Man Group’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,500
Closed -$47.6K – 1949
2022
Q1 		$76K Buy
+10,500
New +$89.5K ﹤0.01% 2086

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Man Group's KRON Position: Q2 2022 in Review

Man Group sold out of Kronos Bio (KRON) in Q2 2022, closing a stake of 10,500 shares — an estimated $47.6K sold.

Man Group first reported a position in KRON in Q1 2022 and held it in 1 quarter. The position peaked at $76K in Q1 2022. 93 funds tracked by Wall St. Rank hold KRON as of Q2 2022.

  • Man Group reported no remaining Kronos Bio position as of Q2 2022 after selling out during the quarter.
  • Man Group sold 10,500 Kronos Bio shares in Q2 2022, an estimated $47.6K.
  • Man Group first reported a position in Kronos Bio in Q1 2022 and held it in 1 quarter.
  • Man Group's Kronos Bio position peaked at $76K in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.